re: Ann: CEO discusses Path Forward for Resub... Dear All,
The latest Open Briefing is compulsory listening for all interested parties. Some very useful general timeframes given and explanation as to the way forward. It is good to hear the conviction in Dr. Holaday's voice as was noticeable in the last Briefing.
There is more clarity as a result of the meetings with the FDA and the road ahead which we should all be satisfied with. The disbelief in the last Briefing was obvious, the satisfaction having meet with the FDA a few times seems to have soothed that disbelief.
The cash position is not a concern for this year which is a positive. I encourage everyone to spend the 43 minutes to listen to the briefing.
Add to My Watchlist
What is My Watchlist?